 |
Open for inclusion |
A phase II, randomized, active-controlled, multi-center study comparing the efficacy and safety of targeted therapy or cancer immunotherapy guided by genomic profiling versus platinum-based chemotherapy in patients with cancer of unknown primary site...Cancer type: Solide tumores Phase: II Principal Investigator: Suonpää Pia Country: FI Keywords: Finland, Helsinki Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03498521 |